Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)
Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)
Data as of 2026-11-05 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1.
This Regulation lays down implementing rules for the listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member States (
1
) or zones or compartments thereof, and the approval of eradication programmes for those listed diseases.
2.
The Annexes to this Regulation list both the Member States or zones or compartments thereof whose disease-free status or eradication programmes shall be deemed to be approved as provided for in Article 280 of Regulation (EU) 2016/429, and those whose disease-free status and eradication programmes shall be duly approved by this Regulation and also duly listed in the Annexes thereto.
3.
This Regulation lists in the Annexes thereto:
(a)
the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases.
(b)
the Member States or zones thereof with approved disease-free status and non-vaccination status;
(c)
the compartments of Member States with recognised disease-free status.
Infection with Brucella abortus , B. melitensis and B. suis
1.
The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part I of Annex I.
2.
The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part I of Annex I.
3.
The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part II of Annex I.
4.
The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part II of Annex I.
Infection with Mycobacterium tuberculosis complex ( M. bovis, M. caprae and M. tuberculosis ) (MTBC)
1.
The Member States or zones thereof with disease-free status from infection with Mycobacterium tuberculosis complex ( Mycobacterium bovis, M.caprae and M. tuberculosis ) (MTBC) shall be listed in Part I of Annex II.
2.
The Member States or zones thereof with an approved compulsory eradication programme for infection with MTBC shall be listed in Part II of Annex II.
1.
The Member States or zones thereof with disease-free status from infection with rabies virus (RABV) shall be listed in Part I of Annex III.
2.
The Member States or zones thereof with an approved compulsory eradication programme for infection with RABV shall be listed in Part II of Annex III.
1.
The Member States or zones thereof with disease-free status from enzootic bovine leukosis (EBL) shall be listed in Part I of Annex IV.
2.
The Member States or zones thereof with an approved optional eradication programme for EBL shall be listed in Part II of Annex IV.
1.
The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.
2.
The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.
1.
The Member States or zones thereof with disease-free status from infection with Aujeszky’s disease virus (ADV) shall be listed in Part I of Annex VI.
2.
The Member States or zones thereof with an approved optional eradication programme for infection with ADV shall be listed in Part II of Annex VI.
1.
The Member States or zones thereof with disease-free status from Bovine viral diarroea (BVD) shall be listed in Part I of Annex VII.
2.
The Member States or zones thereof with an approved optional eradication programme for infection with BVD shall be listed in Part II of Annex VII.
The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.
Infection with highly pathogenic avian influenza (HPAI)
1.
The following shall be listed in Part I of Annex XII:
(a)
Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS);
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
(c)
zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XII:
(a)
Member States where their whole territory has an approved eradication programme for VHS;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and
(c)
zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
1.
The following shall be listed in Part I of Annex XIII:
(a)
Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN);
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and
(c)
zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XIII:
(a)
Member States where their whole territory has an approved eradication programme for IHN;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
(c)
zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)
1.
The following shall be listed in Part I of Annex XIV:
(a)
Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
(c)
zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XIV:
(a)
Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
(c)
zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
1.
The following shall be listed in Part I of Annex XV:
(a)
Member States where their whole territory has disease-free status from infection with Marteilia refringens ;
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens ; and
(c)
zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XV:
(a)
Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens ;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens ; and
(c)
zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
1.
The following shall be listed in Part I of Annex XVI:
(a)
Member States where their whole territory has disease-free status from infection with Bonamia exitiosa ;
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa ; and
(c)
zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XVI:
(a)
Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa ;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa ; and
(c)
zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
1.
The following shall be listed in Part I of Annex XVII:
(a)
Member States where their whole territory has disease-free status from infection with Bonamia ostreae ;
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae ; and
(c)
zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XVII:
(a)
Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae ;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae ; and
(c)
zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
1.
The following shall be listed in Part I of Annex XVIII:
(a)
Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV);
(b)
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
(c)
zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.
The following shall be listed in Part II of Annex XVIII:
(a)
Member States where their whole territory has an approved eradication programme for infection with WSSV;
(b)
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
(c)
zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
It shall apply from 21 April 2021.
Supplementary provisions
INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUIS
ANNEX I
INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUIS
PART I
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis
CHAPTER 1
Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member State ( *1 )
Territory
Belgium
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Spain
Whole territory
France
Whole territory
Croatia
Whole territory
Italy
Regione Abruzzo: Provincia di Pescara, Teramo, Chieti
Regione Basilicata: Provincia di Matera
Regione Calabria: Provincia di Vibo Valentia
Regione Campania: Provincia di Avellino, Benevento, Napoli
Regione Emilia-Romagna
Regione Friuli Venezia Giulia
Regione Lazio
Regione Liguria
Regione Lombardia
Regione Marche
Regione Molise
Regione Piemonte
Regione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, Lecce
Regione Sicilia: Provincia de Agrigento, Trapani, Caltanissetta
Regione Sardegna
Regione Toscana
Regione Trentino – Alto Adige
Regione Umbria
Regione Valle d’Aosta
Regione Veneto
Cyprus
Whole territory
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory
Malta
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Distritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, Viseu
Região Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira
Romania
Whole territory
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
CHAPTER 2
Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member State ( *1 )
Territory
Belgium
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Spain
Whole territory
France
Whole territory
Croatia
Whole territory
Italy
Regione Abruzzo
Regione Basilicata: Province di Matera
Regione Calabria: Province di Catanzaro, Cosenza
Regione Campania: Provincia di Benevento, Napoli, Salerno
Regione Emilia-Romagna
Regione Friuli Venezia Giulia
Regione Lazio
Regione Liguria
Regione Lombardia
Regione Marche
Regione Molise
Regione Piemonte: Provincia de Asti, Biella, Cuneo, Novara, Verbano-Cusio-Ossola, Vercelli and Citta Metropolitana di Torino
Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto
Regione Sardegna
Regione Toscana
Regione Trentino – Alto Adige
Regione Umbria
Regione Valle d’Aosta
Regione Veneto
Cyprus
Whole territory
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Região Autónoma dos Açores
Romania
Whole territory
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis
CHAPTER 1
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member State
Territory
Bulgaria
Whole territory
Greece
Whole territory
—————
Italy
Regione Abruzzo: Provincia dell’Aquila, Regione Basilicata: Provincia di Potenza
Regione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio Calabria
Regione Campania: Provincia di Caserta, Salerno
Regione Puglia: Provincia di Foggia, Taranto
Regione Sicilia except the Provincia of Agrigento,Trapani, Caltanissetta
Portugal
Distritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila Real
Região Autónoma da Madeira
Região Autónoma dos Açores: Ilha de São Miguel
CHAPTER 2
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member State
Territory
Bulgaria
Whole territor
—————
Greece
Whole territory
Italy
Regione Basilicata: Provincia di Potenza
Regione Calabria: Province di Crotone, Reggio Calabria, Vibo Valentia
Regione Campania: Provincia d’Avellino, Caserta
Regione Piemonte: Provincia di Alessandria
Regione Puglia: Provincia di Foggia
Regione Sicilia
Portugal
Região Madeira
Distritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)
ANNEX II
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)
PART I
Member States or zones thereof with disease-free status from infection with MTBC
Member State
Territory
Belgium
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Spain
Comunidad Autónoma de Aragón: provincia de Huesca
Comunidad Autónoma de Canarias
Comunidad Autónoma de Castilla y León: provincias de Burgos, León, Valladolid
Comunidad Autónoma de Cataluña
Comunidad Autónoma de Galicia
Comunidad Autónoma de Islas Baleares
Comunidad Autónoma de Murcia
Comunidad Autónoma del País Vasco
Comunidad Autónoma del Principado de Asturias
France
Whole territory
Croatia
Whole territory
Italy
Regione Abruzzo
Regione Basilicata: Provincia di Matera
Regione Calabria: Provincia di Catanzaro
Regione Campania: Provincia di Napoli
Regione Emilia-Romagna
Regione Friuli Venezia Giulia
Regione Lazio: Province di Frosinone, Latina, Rieti, Viterbo
Regione Liguria
Regione Lombardia
Regione Marche: Province di Ancona, Ascoli Piceno, Fermo, Pesaro-Urbino
Regione Molise
Regione Piemonte
Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto
Regione Sardegna
Regione Toscana
Regione Trentino – Alto Adige
Regione Umbria
Regione Valle d’Aosta
Regione Veneto
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Região Algarve: all distritos
Região Autónoma dos Açores except Ilha de São Miguel
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
PART II
Member States or zones thereof with an approved eradication programme for infection with MTBC
Member State ( *1 )
Territory
Bulgaria
Whole territory
—————
Cyprus
Whole territory
Greece
Whole territory
Ireland
Whole territory
Italy
Regione Basilicata: Provincia di Potenza
Regione Calabria: Province di Cosenza, Crotone, Reggio Calabria, Vibo Valentia
Regione Campania: Province d’Avellino, Caserta, Benevento, Salerno
Regione Lazio: Provincia di Roma
Regione Marche: Provincia di Macerata
Regione Puglia: Provincia di Foggia
Regione Sicilia
Malta
Whole territory
Portugal
Região Autónoma dos Açores: Ilha de São Miguel
Região Autónoma da Madeira
Distritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
Romania
Whole territory
Spain
Comunidad Autónoma de Andalucía
Comunidad Autónoma de Aragón
Comunidad Autónoma de Cantabria
Comunidad Autónoma de Castilla-La Mancha
Comunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, Zamora
Comunidad Autónoma de Extremadura
Comunidad Autónoma de La Rioja
Comunidad Autónoma de Madrid
Comunidad Autónoma de Navarra
Comunidad Autónoma de Valencia
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
ANNEX III
INFECTION WITH THE RABIES VIRUS (RABV)
PART I
Member States or zones thereof with disease-free status from infection with RABV
Member State ( *1 )
Territory
Belgium
Whole territory
Bulgaria
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Greece
Whole territory
Spain
Whole territory
France
Whole territory
Croatia
Whole territory
Italy
Whole territory
Cyprus
Whole territory
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory except Szabolcs-Szatmár-Bereg megye
Malta
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Voivodship Dolnośląskie: all powiaty
Voivodship Kujawsko-pomorskie: all powiaty
Voivodship Lubelskie the following powiaty: łukowski, rycki, puławski, opolski, kraśnicki, janowski, lubelski, m. Lublin, lubartowski, radzyński, parczewski, bialski, m. Biała Podlaska
Voivodship Lubuskie: all powiaty
Voivodship Łódzkie: all powiaty
Voivodship Małopolskie: all powiaty
Voivodship Mazowieckie: all powiaty
Voivodship Opolskie: all powiaty
Voivodeship Podkarpackie the following powiaty: stalowowolski, tarnobrzeski, m. Tarnobrzeg, niżański, leżajski, łańcucki
Voivodship Podlaskie: all powiaty
Voivodship Pomorskie: all powiaty
Voivodship Śląskie: all powiaty
Voivodship Świętokrzyskie: all powiaty
Voivodship Warmińsko-mazurskie: all powiaty
Voivodship Wielkopolskie: all powiaty
Voivodship Zachodniopomorskie: all powiaty
Portugal
Whole territory
Slovenia
Whole territory
Slovakia
Whole territory, except the following regions:
Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský
Michalovce, Sobrance, Trebišov in kraj Košický
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for infection with RABV
Member State
Territory
Hungary
Szabolcs-Szatmár-Bereg megye
Poland
Voivodship Lubelskie the following powiaty: włodawski, łęczyński, świdnicki, krasnostawski, zamojski, m. Zamość, biłgorajski, chełmski, m. Chełm, hrubieszowski, tomaszowski
Voivodship Podkarpackie: the following powiaty: lubaczowski, przeworski, jarosławski, rzeszowski, m. Rzeszów, strzyżowski, krośnieński, m. Krosno, sanocki, leski, bieszczadzki, przemyski, m. Przemyśl, Brzozowski, ropczycko-sędziszowski, jasielski, dębicki, mielecki, kolbuszowski
Romania
Whole territory
Slovakia
Region Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský
Region Michalovce, Sobrance, Trebišov in kraj Košický
ANNEX IV
ENZOOTIC BOVINE LEUKOSIS (EBL)
PART I
Member States or zones thereof with disease-free status from EBL
Member State ( *1 )
Territory
Belgium
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Spain
Whole territory
France
Région Auvergne et Rhône-Alpes
Région Bourgogne-Franche-Comté
Région Bretagne
Région Centre-Val de Loire
Région Corse
Région Grande Est
Région Hauts-de-France
Région Ile-de-France
Région Normandie
Région Nouvelle-Aquitaine
Région Occitanie
Région Pays de la Loire
Région Provence-Alpes-Côte d’Azur
Région Guadeloupe
Région Guyane
Région Martinique
Région Mayotte
Croatia
Whole territory
Italy
Whole territory
Cyprus
Whole territory
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Whole territory, except Região Autónoma da Madeira
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for EBL
Member State
Territory
Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
—————
ANNEX V
INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)
PART I
Member States or zones thereof with disease-free status from IBR/IPV
Member State
Territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Italy
Regione Valle d’Aosta
Regione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige
Austria
Whole territory
Finland
Whole territory
Sweden
Whole territory
PART II
Member States or zones thereof with an approved eradication programme for IBR/IPV
Member State
Territory
Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689
Belgium
Whole territory
21 April 2021
France
Région Auvergne et Rhône-Alpes
Région Bourgogne-Franche-Comté
Région Bretagne
Région Centre-Val de Loire
Région Grande Est
Région Hauts-de-France
Région Ile-de-France
Région Normandie
Région Nouvelle-Aquitaine
Région Occitanie
Région Pays de la Loire
Région Provence-Alpes-Côte d’Azur
21 April 2021
Italy
Region Friuli Venezia Giulia
Regione Trentino – Alto Adige: Provincia Autonoma di Trento
21 April 2021
Luxembourg
Whole territory
21 April 2021
Slovakia
Kraj Bratislava
Kraj Košice
Kraj Prešov
Kraj Trnava
Kraj Žilina
5 June 2023
ANNEX VI
AUJESZKY’S DISEASE VIRUS (ADV)
PART I
Member States or zones thereof with disease-free status from infection with ADV
Member State ( *1 )
Territory
Belgium
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
France
The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
Italy
Regione Friuli Venezia Giulia
Regione Trentino – Alto Adige
Regione Veneto
Cyprus
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Região Autónoma dos Açores
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for infection with ADV
Member State
Territory
Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689
Spain
Whole territory
21 April 2021
Italy
Regione Abruzzo
Regione Apulia
Regione Basilicata
Regione Calabria
Regione Campania
Regione Emilia-Romagna
Regione Lazio
Regione Liguria
Regione Lombardia
Regione Marche
Regione Molise
Regione Piemonte
Regione Sicilia
Regione Toscana
Regione Valle d’Aosta
Regione Umbria
21 April 2021
Lithuania
Whole territory
21 April 2021
—————
Portugal
Whole peninsular territory
21 April 2021
ANNEX VII
BOVINE VIRAL DIARRHOEA (BVD)
PART I
Member States or zones thereof with disease-free status from BVD
Member State
Territory
Austria
Whole territory
Denmark
Whole territory
Finland
Whole territory
Germany
Bundesland Baden-Württemberg
Bundesland Bayern
Bundesland Brandenburg
Bundesland Bremen
Bundesland Hamburg
Bundesland Hessen
Bundesland Mecklenburg-Vorpommern
Bundesland Niedersachsen, except Landkreis Cuxhaven
Bundesland Nordrhein-Westfalen, except Kreis Höxter
Bundesland Schleswig-Holstein
Bundesland Rheinland-Pfalz
Bundesland Saarland
Bundesland Sachsen
Bundesland Sachsen-Anhalt
Bundesland Thüringen
Sweden
Whole territory
PART II
Member States or zones thereof with an approved eradication programme for BVD
Member State
Territory
Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
Germany
Bundesland Berlin
Bundesland Niedersachsen: Landkreis Cuxhaven
Bundesland Nordrhein-Westfalen: Kreis Höxter
21.2.2022
Ireland
Whole territory
18 July 2022
ANNEX IX
INFESTATION WITH VARROA SPP.
Member States or zones thereof with disease-free status from infestation with Varroa spp.
Member State
Territory
Portugal
Island of Corvo
Island of Graciosa
Island of São Jorge
Island of Santa Maria
Island of São Miguel
Island of Terceira
Finland
Åland Islands, except the municipality of Brändö
ANNEX IX
INFESTATION WITH VARROA SPP.
Member States or zones thereof with disease-free status from infestation with Varroa spp.
Member State
Territory
Portugal
Island of Corvo
Island of Graciosa
Island of São Jorge
Island of Santa Maria
Island of São Miguel
Island of Terceira
Finland
Åland islands
ANNEX X
INFECTION WITH NEWCASTLE DISEASE VIRUS
Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination
Member State
Territory
Finland
Whole territory
ANNEX XI
HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)
Compartments free from HPAI
Member State
Name
France
Compartiment ISA Bretagne comprising the establishments with codes EDE 22080055, 22277180, 22203429, 22059174 and 22295000.
Compartiment SASSO Sabres comprising the establishment with Code EDE 40246082.
Compartiment SASSO Soulitré comprising the establishment with Code EDE 72341105.
Netherlands
Verbeek’s poultry international B.V with approval number 1122.
Institut de selection animale B.V with approval number 2338.
Cobb Europe B.V. with approval number 2951.
ANNEX XI
HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)
Compartments free from HPAI
Member State
Name
France
ISA Bretagne, consisting in the establishments EDE 22080055, EDE 22277180, EDE 22203429, EDE 22059174 and EDE 22295000;
SASSO Sabres, consisting in the establishment EDE 40246082;
SASSO Soulitré, consisting in the establishment EDE 72341105.
The Netherlands
Institut de selection animale B.V, with approval number 2338, consisting in the following companies:
— Institut de Selection Animale B.V., St. Anthonisweg 65 B, 5831 AD Boxmeer
— ISA Siebengewald, Horsterbeekweg 5, 5853 GD Siebengewald
— ISA Landhorst, Boekelsebaan 16, 5445 NH Landhorst
— Mts. Everts, Riegshoogtendijk 146, 7913 TC Hollandscheveld
— Mts. Van der Zee, Bakkeveenseweg 1, 9343 TB Een-West
— Scherpenkate, Oosterkampen 2, 7722 VZ Dalfsen
— Mts. Steverink, Dinxperloseweg 26b, 7064 LA Silvolde
— Melitz V.O.F. Zeewolde, Ooievaarsweg 5, 3897 LG, Zeewolde.
ANNEX XII
VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)
PART I
Member States whose whole territory has disease-free status from VHS;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Denmark
Whole continental territory
Ireland
Whole territory
Cyprus
Whole continental territory
Finland
Whole territory, except the Province of Åland
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
PART II
Member States where their whole territory has an approved eradication programme for VHS;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;
and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State
Territory
Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
Estonia
Whole territory
21 April 2021
( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
ANNEX XII
VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)
PART I
Member States whose whole territory has disease-free status from VHS;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Denmark
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Cyprus
Whole continental territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for VHS;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;
and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State
Territory
Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
—————
ANNEX XIII
INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)
PART I
Member States where their whole territory has disease-free status from IHN;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;
and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Denmark
Whole territory
Ireland
Whole territory
Cyprus
Whole continental territory
Finland
Whole territory, except the coastal compartment in Ii, Kuivaniemi, and the following water catchment areas: 14.72 Virmasvesi, 14.73 Nilakka, 4.74 Saarijärvi area and 4.41 Pielinen area
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
PART II
Member States where their whole territory has an approved eradication programme for IHN;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State
Territory
Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
Estonia
Whole territory
21 April 2021
( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
ANNEX XIII
INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)
PART I
Member States where their whole territory has disease-free status from IHN;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;
and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
—————
Estonia
Whole territory
Ireland
Whole territory
Cyprus
Whole continental territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for IHN;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State
Territory
Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
—————
INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
ANNEX XIV
INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
PART I
Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Belgium
Whole territory
Bulgaria
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Greece
Whole territory
Spain
Whole territory
France
Whole territory
Croatia
Whole territory
Italy
Whole territory
Cyprus
Whole territory
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory
Malta
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Whole territory
Romania
Whole territory
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
PART II
Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
ANNEX XIV
INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
PART I
Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Belgium
Whole territory
Bulgaria
Whole territory
Czechia
Whole territory
Denmark
Whole territory
Germany
Whole territory
Estonia
Whole territory
Ireland
Whole territory
Greece
Whole territory
Spain
Whole territory
France
Whole territory
Croatia
Whole territory
Italy
Whole territory
Cyprus
Whole territory
Latvia
Whole territory
Lithuania
Whole territory
Luxembourg
Whole territory
Hungary
Whole territory
Malta
Whole territory
Netherlands
Whole territory
Austria
Whole territory
Poland
Whole territory
Portugal
Whole territory
Romania
Whole territory
Slovenia
Whole territory
Slovakia
Whole territory
Finland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XV
INFECTION WITH MARTEILIA REFRINGENS
PART I
Member States where their whole territory has disease-free status from infection with Marteilia refringens ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and
zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Ireland
Whole territory
United Kingdom (Northern Ireland)
The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay.
PART II
Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and
zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
ANNEX XV
INFECTION WITH MARTEILIA REFRINGENS
PART I
Member States where their whole territory has disease-free status from infection with Marteilia refringens ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and
zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Ireland
Whole territory
Sweden
Whole territory
United Kingdom (Northern Ireland)
The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay.
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and
zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVI
INFECTION WITH BONAMIA EXITIOSA
PART I
Member States where their whole territory has disease-free status from infection with Bonamia exitiosa ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and
zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State
Territory
Estonia
Whole territory
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVI
INFECTION WITH BONAMIA EXITIOSA
PART I
Member States where their whole territory has disease-free status from infection with Bonamia exitiosa ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and
zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State
Territory
Estonia
Whole territory
Sweden
Whole territory
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVII
INFECTION WITH BONAMIA OSTREAE
PART I
Member States where their whole territory has disease-free status from infection with Bonamia ostreae ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and
zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Estonia
Whole territory
Ireland
The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; and Kilkieran Bay.
United Kingdom (Northern Ireland)
The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough.
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
ANNEX XVII
INFECTION WITH BONAMIA OSTREAE
PART I
Member States where their whole territory has disease-free status from infection with Bonamia ostreae ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and
zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 )
Territory
Estonia
Whole territory
Ireland
The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; Kilkieran Bay and Bertrabhoy Bay
Sweden
Whole territory except the coastal area from Altarefjorden in the north until Sälö fjord in the south.
United Kingdom (Northern Ireland)
The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough.
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVIII
INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)
PART I
Member States where their whole territory has disease-free status from infection with WSSV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
PART II
Member States where their whole territory has an approved eradication programme for infection with WSSV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVIII
INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)
PART I
Member States where their whole territory has disease-free status from infection with WSSV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
PART II
Member States where their whole territory has an approved eradication programme for infection with WSSV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XIX
INFESTATION WITH ECHINOCOCCUS MULTILOCULARIS
PART I
Member States or zones thereof with disease-free status from infestation with Echinococcus multilocularis in accordance with the conditions laid down in Annex V, Part V, Section 2, point (1), of Delegated Regulation (EU) 2020/689
Member State
Territory
Malta
Whole territory
PART II
Member States or zones thereof with disease-free status from infestation with Echinococcus multilocularis , in accordance with the conditions laid down in Annex V, Part V, Section 2, point (2), of Delegated Regulation (EU) 2020/689
Member State ( *1 )
Territory
Finland
Whole territory
Ireland
Whole territory
United Kingdom (Northern Ireland)
Northern Ireland
( *1 )
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (OJ L 102, 17.4.2023, p. 87)) in conjunction with Annex 2 to that Framework, for the purposes of this Annex, references to Member States include the United Kingdom in respect of Northern Ireland.
